Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of PLPP5 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | decreases expression | ISO | Plpp5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PLPP5 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Plpp5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLPP5 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Estradiol results in increased expression of PLPP5 mRNA | CTD | PMID:20106945 | 17beta-estradiol | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of PLPP5 mRNA | CTD | PMID:23019147 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of PLPP5 mRNA | CTD | PMID:29581250 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:19095052 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of PLPP5 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of PLPP5 mRNA | CTD | PMID:24780913 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of PLPP5 mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of PLPP5 mRNA | CTD | PMID:33167477 | arsenite(3-) | increases methylation | ISO | PLPP5 (Homo sapiens) | 6480464 | arsenite results in increased methylation of PLPP5 promoter | CTD | PMID:23974009 | belinostat | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | belinostat results in decreased expression of PLPP5 mRNA | CTD | PMID:27188386 | benzo[a]pyrene diol epoxide I | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PLPP5 mRNA | CTD | PMID:25181051 | bisphenol A | affects expression | ISO | PLPP5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of PLPP5 mRNA | CTD | PMID:30903817 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of PLPP5 promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PLPP5 mRNA | CTD | PMID:25993096 | carbamazepine | affects expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of PLPP5 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | CGP 52608 | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PLPP5 gene] | CTD | PMID:28238834 | cisplatin | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PLPP5 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of PLPP5 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of PLPP5 mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of PLPP5 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of PLPP5 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of PLPP5 mRNA | CTD | PMID:20106945 more ... | decabromodiphenyl ether | affects expression | ISO | PLPP5 (Homo sapiens) | 6480464 | decabromobiphenyl ether affects the expression of PLPP5 mRNA | CTD | PMID:24834073 | deoxynivalenol | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of PLPP5 mRNA | CTD | PMID:31863870 | dexamethasone | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of PLPP5 mRNA | CTD | PMID:25047013 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of PLPP5 mRNA | CTD | PMID:21551480 | diuron | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Diuron results in decreased expression of PLPP5 mRNA | CTD | PMID:35967413 | dorsomorphin | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of PLPP5 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of PLPP5 mRNA | CTD | PMID:29391264 | entinostat | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | entinostat results in decreased expression of PLPP5 mRNA | CTD | PMID:27188386 | ethanol | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Ethanol results in increased expression of PLPP5 mRNA | CTD | PMID:19167417 | folic acid | multiple interactions | ISO | Plpp5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLPP5 mRNA | CTD | PMID:22206623 | genistein | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Genistein results in increased expression of PLPP5 mRNA | CTD | PMID:26865667 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of PLPP5 mRNA | CTD | PMID:24136188 | indometacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PLPP5 mRNA | CTD | PMID:36868495 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of PLPP5 mRNA | CTD | PMID:30467583 | methidathion | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | methidathion results in increased expression of PLPP5 mRNA | CTD | PMID:34813904 | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of PLPP5 mRNA | CTD | PMID:24136188 | paracetamol | affects expression | ISO | Plpp5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PLPP5 mRNA | CTD | PMID:17562736 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of PLPP5 mRNA | CTD | PMID:28903501 | propiconazole | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | propiconazole results in increased expression of PLPP5 mRNA | CTD | PMID:21278054 | SB 431542 | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of PLPP5 mRNA | CTD | PMID:23221170 | sodium arsenite | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PLPP5 mRNA | CTD | PMID:28595984 and PMID:34032870 | sodium arsenite | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of PLPP5 mRNA | CTD | PMID:37682722 | sunitinib | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of PLPP5 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of PLPP5 mRNA | CTD | PMID:33848595 | tetrachloromethane | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of PLPP5 mRNA | CTD | PMID:27339419 and PMID:31919559 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of PLPP5 mRNA | CTD | PMID:31150632 | thapsigargin | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of PLPP5 mRNA | CTD | PMID:22378314 and PMID:29453283 | trichostatin A | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of PLPP5 mRNA | CTD | PMID:24935251 more ... | trichostatin A | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA | CTD | PMID:27188386 | triptonide | increases expression | ISO | Plpp5 (Mus musculus) | 6480464 | triptonide results in increased expression of PLPP5 mRNA | CTD | PMID:33045310 | tunicamycin | increases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of PLPP5 mRNA | CTD | PMID:22378314 and PMID:29453283 | valproic acid | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PLPP5 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | PLPP5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PLPP5 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | PLPP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | PLPP5 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of PLPP5 mRNA | CTD | PMID:27188386 | |